Instructions de recherche:
* Filter the ENTIRE resource library: Choose a OR a to sort all resources.
* Choose Search Items : to filter one collection or perform complex queries.
* Choose Browse by Topic to search by one or more Topics.
Parcourir les contenus (18 total)
-
Créateur: Wong, K. K., R. T. Davey, Jr., A. L. Hewlett, C. S. Kraft, A. K. Mehta, M. J. Mulligan, A. Beck, W. Dorman, C. J. Kratochvil, L. Lai, T. N. Palmore, S. Rogers, P. W. Smith, A. F. Suffredini, M. Wolcott, U. Stroher and T. M. Uyeki
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2016-08-01
Description: From September 2014 to April 2015, 6 persons who had occupational exposures to Zaire ebolavirus in West Africa received investigational agent rVSV-ZEBOV or TKM-100802 for postexposure prophylaxis and were monitored in the United States.Example only: NETEC provides this item for reference purposes but does not endorse its content. Newer versions may be in place at the providing institution.
-
Créateur: National Institute of Allergy and Infectious Diseases [National Institutes of Health] NIH (NIAID)
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2019-01-04
Description: The 2014-2016 Ebola outbreak in West Africa was the largest in history, with nearly 28,700 cases and more than 11,300 deaths. As local and international healthcare workers responded to the outbreak, the U.S. National Institute of Allergy and… -
Créateur: U.S. Food and Drug Administration
Sujet: Treatment & Care
Type d'élément: Guide
Date de la dernière mise à jour: 2017-09-08
Description: This site lists products for Botulism due to Clostridium botulinum toxin; Ebola Virus Disease (EVD); Glanders and Melioidosis due to Burkholderia mallei and B. pseudomallei, respectively; Plague due to Yersinia pestis; Smallpox due to Variola major… -
Créateur: World Health Organization
Sujet: General
Type d'élément: Guide
Date de la dernière mise à jour: 2022
Description: Worldwide, the number of potential pathogens is very large, while the resources for disease research and development (R&D) is limited. To ensure efforts under WHO’s R&D Blueprint are focused and productive, a list of diseases and pathogens are… -
Créateur: Varkey, J. B. and B. S. Ribner
Sujet: General
Type d'élément: Publication
Date de la dernière mise à jour: 2016-06-01
Description: Ending the West Africa Ebola virus disease (EVD) outbreak required an unprecedented international response. -
Créateur: University of Nebraska Medical Center / Nebraska Medicine
Sujet: General
Type d'élément: Webinaire
Date de la dernière mise à jour: 2018-01-08
Description: Resources - National Ebola Training and Education CenterExample only: NETEC provides this item for reference purposes but does not endorse its content. Newer versions may be in place at the providing institution.
-
Créateur: National Academies Press
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2017-04-12
Description: Table of Contents Front Matter i-xxvi Summary 1-18 1 Introduction 19-36 2 Conducting Clinical Research During an Epidemic 37-82 3 Assessment of Therapeutic Trials 83-112 4 Assessment of Vaccine Trials 113-154 5… -
Créateur: Johns Hopkins Center for Health Security
Sujet: Emergency Management
Type d'élément: Publication
Date de la dernière mise à jour: 2016-11-07
Description: Summary Chapter 1 - Introduction Chapter 2 - Ebola Chapter 3 - Fukushima Chapter 4 - H1N1 InfluenzaChapter 5 - Anthrax Letters Enhanced Accessibility -
Créateur: Angie M. Boyce and Brian T. Garibaldi.
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2019-02-19
Description: Host genomic research on high-consequence infectious diseases is a growing area, but the ethical, legal, and social implications of such findings related to potential applications of the research have not yet been identified. -
Créateur: U.S. Food and Drug Administration (FDA)
Sujet: Research
Type d'élément: Guide
Date de la dernière mise à jour: 2018-08-13
Description: FDA CDER statisticians are designing trials with adaptive features to make clinical evaluation of new drug treatments more efficient and informative. (FDA)More information on the subject can be read here.